Skip to main content

MMI Receives FDA Authorization to Commercialize Symani in US

First and Only Commercially Available System in the U.S. Designated for Reconstructive Microsurgery

Share

Powered by
►
Necessary cookies enable essential site features like secure log-ins and consent preference adjustments. They do not store personal data.
None
►
Functional cookies support features like content sharing on social media, collecting feedback, and enabling third-party tools.
None
►
Analytical cookies track visitor interactions, providing insights on metrics like visitor count, bounce rate, and traffic sources.
None
►
Advertisement cookies deliver personalized ads based on your previous visits and analyze the effectiveness of ad campaigns.
None
Powered by

To watch this Professional Presentation, please submit your details.

To watch this Professional Presentation, please submit your details.

To watch this Professional Presentation, please submit your details.

To watch this Professional Presentation, please submit your details.

To watch this Professional Presentation, please submit your details.

To watch this Professional Presentation, please submit your details.

To watch this Microchat, please submit your details.